Medicinal Chemistry Reviews

Volume 51, Chapter 1

Lessons From Decades of R&D Management

Chapter 1

1.    The Early Pfizer Years                                                                                                     4   

2.   Transition to Management                                                                                                  6

3.   The 1990s and Pfizer’s Rise to Prominence                                                                       7

4.   The Beginning of the Mega-Mergers                                                                                   9

5.   And Now for Something Completely Different                                                                12

6.   Final Thoughts                                                                                                                     14

To purchase a copy, contact secretary@acsmedchem.org

ACS Division of Medicinal Chemistry

Webmaster:  secretary@acsmedchem.org